WallStreetZenWallStreetZen

NASDAQ: DCPH
Deciphera Pharmaceuticals Inc Stock Ownership - Who owns Deciphera Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Deciphera Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brightstar Associates LLC10% Owner2024-04-2248,136$0.01
$481.36Buy
Thomas Patrick KellyChief Financial Officer2024-02-163,010$15.62
$47.01kSell
Jama PitmanSVP Chief Development Officer2024-02-162,267$15.62
$35.41kSell
Daniel C. MartinChief Commercial Officer2024-02-162,267$15.62
$35.41kSell
Matthew L. ShermanEVP Chief Medical Officer2024-02-162,615$15.62
$40.84kSell
Brightstar Associates LLC10% Owner2024-02-07914,001$0.01
$9.14kBuy
Daniel C. MartinChief Commercial Officer2024-01-161,624$14.47
$23.50kSell
Jama PitmanSVP Chief Development Officer2024-01-161,624$14.47
$23.50kSell
Matthew L. ShermanEVP Chief Medical Officer2024-01-162,435$14.47
$35.23kSell
Thomas Patrick KellyChief Financial Officer2024-01-162,435$14.47
$35.23kSell

1 of 3

DCPH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DCPH insiders and whales buy or sell their stock.

DCPH Shareholders

What type of owners hold Deciphera Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Brightstar Associates LLC28.60%23,107,844$338.53MInsider
Blackrock Inc7.40%5,976,266$87.55MInstitution
Deerfield Management Company LP Series C7.16%5,788,024$84.79MInstitution
Armistice Capital LLC6.44%5,200,000$76.18MInstitution
Redmile Group LLC5.94%4,801,540$70.34MInstitution
Vanguard Group Inc5.45%4,401,636$64.48MInstitution
State Street Corp3.06%2,470,813$36.20MInstitution
Morgan Stanley2.87%2,316,433$33.94MInstitution
Goldman Sachs Group Inc2.86%2,307,475$33.80MInstitution
Liam Ratcliffe2.66%2,146,308$31.44MInsider

1 of 3

DCPH vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DCPH67.07%32.93%Net BuyingNet Buying
COLL58.62%41.38%Net SellingNet Selling
IRWD72.14%27.86%Net SellingNet Selling
PCRX68.56%31.44%Net SellingNet Selling
ANIP21.94%78.06%Net SellingNet Selling
View Top Pharmaceutical Stocks

Deciphera Pharmaceuticals Stock Ownership FAQ

Who owns Deciphera Pharmaceuticals?

Deciphera Pharmaceuticals (NASDAQ: DCPH) is owned by 71.72% institutional shareholders, 35.22% Deciphera Pharmaceuticals insiders, and 0.00% retail investors. Brightstar Associates LLC is the largest individual Deciphera Pharmaceuticals shareholder, owning 23.11M shares representing 28.60% of the company. Brightstar Associates LLC's Deciphera Pharmaceuticals shares are currently valued at $338.53M.

If you're new to stock investing, here's how to buy Deciphera Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.